Smarter radiation for prostate cancer: study aims to reduce side effects

NCT ID NCT07344844

First seen Jan 17, 2026 · Last updated May 24, 2026 · Updated 18 times

Summary

This study is testing a more precise type of radiation therapy for prostate cancer called adaptive stereotactic body radiotherapy (SBRT). It compares the standard approach to one that adjusts the radiation dose based on daily changes in bladder and rectal filling. The goal is to see if this adaptation can better protect nearby organs and maintain quality of life. The study will enroll 100 men aged 60 or older with low- or intermediate-risk localized prostate cancer and follow them for 24 months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER (ADENOCARCINOMA) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Clinique Sainte Clotilde

    RECRUITING

    Saint-Denis, 97404, Reunion

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.